indication_prescribing_txt_id
int64
7.6k
33.5k
condition
stringlengths
4
213
episodicity
stringclasses
21 values
severity
stringclasses
93 values
schedule_code
int64
3.67k
3.67k
9,805
Chronic liver failure with fat malabsorption
null
null
3,671
9,806
Chylous ascites
null
null
3,671
9,807
Enterokinase deficiency
null
null
3,671
9,808
Proven fat malabsorption
null
null
3,671
9,809
Severe diarrhoea of greater than 2 weeks duration
null
null
3,671
9,817
Chylothorax
null
null
3,671
9,818
breast cancer
null
Locally advanced or metastatic
3,671
9,823
mania
null
Acute
3,671
9,828
non-small cell lung cancer (NSCLC)
null
Stage IIIB (locally advanced) or Stage IV (metastatic)
3,671
9,926
plaque type psoriasis vulgaris
Chronic
stable
3,671
9,946
Migraine attack
null
null
3,671
9,952
Urea cycle disorders
null
null
3,671
9,976
Urethritis
null
null
3,671
9,978
Mobilisation of haematopoietic stem cells
null
null
3,671
9,993
ulcerative proctitis
Acute episode of
mild to moderate
3,671
9,994
Peroxisomal biogenesis disorders
null
null
3,671
9,995
Pelvic inflammatory disease
null
null
3,671
9,996
Bronchiectasis
null
null
3,671
9,998
bronchitis
Chronic
null
3,671
10,002
acne
null
Severe
3,671
10,054
Proven inborn errors of protein metabolism
null
null
3,671
10,061
ulcerative colitis
Acute
severe
3,671
10,078
Paget disease of bone
null
Symptomatic
3,671
10,080
Hypercalcaemia of malignancy
null
null
3,671
10,086
active juvenile idiopathic arthritis
null
Severe
3,671
10,186
Glioblastoma multiforme
null
null
3,671
10,191
Dietary management of conditions requiring a source of medium chain triglycerides
null
null
3,671
10,205
Homocystinuria
null
null
3,671
10,206
migraine
Chronic
null
3,671
10,215
soft tissue sarcoma
null
Advanced (unresectable and/or metastatic)
3,671
10,242
Unresectable locally advanced or metastatic triple-negative breast cancer
null
null
3,671
10,306
Contraception
null
null
3,671
10,324
scalp psoriasis
null
Moderate to severe
3,671
10,326
Pulmonary arterial hypertension (PAH)
null
null
3,671
10,431
hepatitis B infection
Chronic
null
3,671
10,608
CD30 positive systemic anaplastic large cell lymphoma
null
null
3,671
10,616
Hyperphenylalaninaemia
null
null
3,671
10,646
Benign prostatic hyperplasia
null
null
3,671
10,651
breast cancer
null
Metastatic (Stage IV)
3,671
10,706
Major depressive disorders
null
null
3,671
10,729
Crusted (Norwegian) scabies
null
null
3,671
10,731
Human sarcoptic scabies
null
null
3,671
10,746
Acromegaly
null
null
3,671
10,755
Functional carcinoid tumour
null
null
3,671
10,762
Vasoactive intestinal peptide secreting tumour (VIPoma)
null
null
3,671
10,826
Hyperphosphataemia
null
null
3,671
10,833
Attention deficit hyperactivity disorder
null
null
3,671
10,846
myelofibrosis
null
High risk and intermediate-2 risk
3,671
10,886
Familial homozygous hypercholesterolaemia
null
null
3,671
10,887
Blepharospasm
null
null
3,671
10,943
Chronic lymphocytic leukaemia (CLL)
null
null
3,671
10,956
differentiated thyroid cancer
null
Locally advanced or metastatic
3,671
11,166
Ankylosing spondylitis
null
null
3,671
11,283
cryopyrin associated periodic syndromes (CAPS)
null
Moderate to severe
3,671
11,290
Crohn disease
null
Severe
3,671
11,291
Central precocious puberty
null
null
3,671
11,306
Secondary hyperparathyroidism
null
null
3,671
11,346
Chronic Myeloid Leukaemia (CML)
null
null
3,671
11,376
Acute lymphoblastic leukaemia
null
null
3,671
11,394
Dietary management of conditions requiring a highly restrictive therapeutic diet
null
null
3,671
11,469
Hyperlipoproteinaemia type 1
null
null
3,671
11,470
Long chain fatty acid oxidation disorders
null
null
3,671
11,471
adenocarcinoma of the pancreas
null
Stage IV (metastatic)
3,671
11,483
Isovaleric acidaemia
null
null
3,671
11,492
generalised anxiety disorder (GAD)
null
Moderate to severe
3,671
11,503
social anxiety disorder (social phobia, SAD)
null
Moderate to severe
3,671
11,514
Prophylaxis of invasive fungal infections including both yeasts and moulds
null
null
3,671
11,561
Systemic aspergillosis
null
null
3,671
11,564
Systemic sporotrichosis
null
null
3,671
11,565
Systemic histoplasmosis
null
null
3,671
11,566
Oropharyngeal candidiasis
null
null
3,671
11,567
Oesophageal candidiasis
null
null
3,671
11,581
fungal infections
null
Serious
3,671
11,585
Candida infections
null
Serious
3,671
11,591
invasive mycosis infections
null
Serious
3,671
11,609
Disseminated pulmonary histoplasmosis infection
null
null
3,671
11,613
pulmonary histoplasmosis infection
Chronic
null
3,671
11,640
ulcerative colitis
null
Moderate to severe
3,671
11,678
For use in patients pre- and post-angioplasty
null
null
3,671
11,686
Severe active rheumatoid arthritis
null
null
3,671
11,715
Atypical haemolytic uraemic syndrome (aHUS)
null
null
3,671
11,847
Maple syrup urine disease
null
null
3,671
11,851
Tyrosinaemia
null
null
3,671
11,873
allergic asthma
Uncontrolled
severe
3,671
12,008
Haemodialysis
null
null
3,671
12,035
Osteoarthritis
null
null
3,671
12,086
Phaeochromocytoma
null
null
3,671
12,087
Neurogenic urinary retention
null
null
3,671
12,109
Idiopathic pulmonary fibrosis
null
null
3,671
12,130
malignant gastrointestinal stromal tumour
null
Metastatic or unresectable
3,671
12,168
Acute promyelocytic leukaemia
null
null
3,671
12,176
squamous cell cancer of the larynx, oropharynx or hypopharynx
null
Stage III, IVa or IVb
3,671
12,226
Ulcerative colitis
null
null
3,671
12,269
Androgen deficiency
null
null
3,671
12,284
Micropenis
null
null
3,671
12,285
Pubertal induction
null
null
3,671
12,286
Constitutional delay of growth or puberty
null
null
3,671
12,312
Breast cancer
null
null
3,671
12,320
carcinoma of the prostate
null
Locally advanced (stage C) or metastatic (stage D)
3,671
12,321
Endometriosis
null
null
3,671